| Drug Name | Afatinib |
|---|---|
| Other Drug Names | BIBW 2992 MA2; BIBW-2992; Gilotrif; Giotrif; Tomtovok; Tovok; Xovoltib |
| Chemical Name | (2E)-N-[4-(3-chloro-4-fluoroanilino)-7-{[(3S)-oxolan-3-yl]oxy}quinazolin-6-yl]-4-(dimethylamino)but-2-enamide |
| Formula | C24H25ClFN5O3 |
| Mol. Wt. | 485.94 |
| CAS No. | 850140-72-6 |
| UNII | 41UD74L59M |
| Target-based Actions | Epidermal growth factor antagonist; Erbb2 tyrosine kinase receptor inhibitor; Erbb3 tyrosine kinase receptor inhibitor; Erbb4 tyrosine kinase receptor inhibitor |
| ATC Codes | L01XE13 |
| Highest Status | 2013年批准上市 |
| Originator Company | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Structure |
 |